Literature DB >> 22613615

Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.

Tong Liu1, Yun Gao, Yu-long Gao, Yu-tong Cheng, Su Wang, Zhi-zhong Li, Hai-Bo Zhang, Xu Meng, Chang-sheng Ma, Jian-zeng Dong.   

Abstract

Left ventricular hypertrophy associated with the use of tacrolimus is a rare complication of solid organ transplantation in adult recipients. We present a cardiac transplant recipient who developed severe concentric left ventricular hypertrophy with congestive heart failure related to myocardial hypertrophy on tacrolimus. Hypertrophy improved when the drug was discontinued and replaced with sirolimus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613615

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  3 in total

1.  Multimodality imaging of hypertrophic cardiomyopathy in a transplanted heart.

Authors:  Siddique A Abbasi; Michael K Cheezum; Nina Ghosh; Garrick C Stewart; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-09-16       Impact factor: 29.690

2.  Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients.

Authors:  Nosheen Reza; Alejandro De Feria; Teresa Wang; Jessica L Chowns; Lily Hoffman-Andrews; Jessica Kim; Nicole Hornsby; Amy Marzolf; Pavan Atluri; Howard C Herrmann; Anjali Tiku Owens
Journal:  Transplant Direct       Date:  2021-12-13

3.  Pirfenidone attenuates cardiac hypertrophy against isoproterenol by inhibiting activation of the janus tyrosine kinase-2/signal transducer and activator of transcription 3 (JAK-2/STAT3) signaling pathway.

Authors:  Zhenhuan Chen; Haiwen Zhou; Xiantao Huang; Shaoyun Wang; Xiaochao Ouyang; Yunxia Wang; Qianqiang Cao; Liu Yang; Yu Tao; Hengli Lai
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.